AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trueglipt M 1000mg/20mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Biospark Pharmaceuticals And Laboratories Pvt Ltd

Salt Composition

Metformin (1000mg) + Teneligliptin (20mg)

Overview Trueglipt M 1000mg/20mg Tablet ER

Metformin/Linagliptin Extended-Release 1000mg/20mg tablets manage elevated blood glucose in type 2 diabetes patients by combining two active ingredients. This dual action mitigates severe diabetic complications like nephropathy and vision loss, potentially lessening cardiovascular events. Trueglipt M ER may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a physician-recommended diet and exercise regimen. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Ingesting this medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar regulation prevents future complications. Maintaining your prescribed diet and exercise program is crucial for diabetes management; lifestyle significantly impacts disease control. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, and cephalalgia. Hypoglycemia is a potential risk, especially with concurrent insulin or sulfonylurea use; learn to identify and manage this event. This medication isn't universally suitable. Inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals require medical consultation. Drug interactions are possible; disclose all medications to your doctor for safety. Alcohol should be limited due to its hypoglycemic effect. Kidney function and blood glucose monitoring occur pre- and post-treatment.

Uses of Trueglipt M 1000mg/20mg Tablet ER

Managing Type 2 Diabetes

Major Benefits of Trueglipt M 1000mg/20mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trueglipt M 1000mg/20mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing. Administer this medication with a meal.

Common Side effects of Trueglipt M 1000mg/20mg Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Trueglipt M 1000mg/20mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Trueglipt M 1000mg/20mg Extended-Release Tablet should be administered with a meal.

How Trueglipt M 1000mg/20mg Tablet ER works:

Metformin and linagliptin, combined in Trueglipt M 1000mg/20mg Extended-Release tablets, offer dual action against elevated blood sugar.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Trueglipt M 1000mg/20mg Extended-Release Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Trueglipt M 1000mg/20mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Trueglipt M 1000mg/20mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Trueglipt M 1000mg/20mg Extended-Release Tablets on driving ability is unknown. Refrain from driving if you encounter symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should use Trueglipt M 1000mg/20mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Use of Trueglipt M 1000mg/20mg Extended-Release tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Trueglipt M 1000mg/20mg Tablet ER :

Should you forget a Trueglipt M 1000mg/20mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Trueglipt M 1000mg/20mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Trueglipt M 1000mg/20mg Tablet ER

Trueglipt M 1000mg/20mg ER tablets are safe when used as prescribed. However, even with correct dosage, common side effects may include nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infections, and hypoglycemia (low blood sugar). Hypoglycemia is more likely if you're also using insulin or sulfonylurea. Report any persistent side effects to your doctor.
Trueglipt M 1000mg/20mg ER tablets rarely cause hypoglycemia alone, but low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Trueglipt M 1000mg/20mg Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Patients with known allergies to Trueglipt M 1000mg/20mg Tablet ER components or excipients should not use this medication. It is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Trueglipt M 1000mg/20mg Tablet ER can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a rare but serious side effect due to elevated blood lactic acid. It's avoided in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Trueglipt M and seek immediate medical attention.
Prolonged use of Trueglipt M 1000mg/20mg Extended-Release tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). If you experience any of these symptoms, consult your physician for potential vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Trueglipt M 1000mg/20mg T...
101
MRP 117
13% off